Details for New Drug Application (NDA): 005794
✉ Email this page to a colleague
NDA 005794 describes SULTRIN, which is a drug marketed by Ortho Mcneil Pharm and is included in one NDA. Additional details are available on the SULTRIN profile page.
The generic ingredient in SULTRIN is triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole). There are five drug master file entries for this compound. Additional details are available on the triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) profile page.
The generic ingredient in SULTRIN is triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole). There are five drug master file entries for this compound. Additional details are available on the triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) profile page.
Summary for 005794
| Tradename: | SULTRIN |
| Applicant: | Ortho Mcneil Pharm |
| Ingredient: | triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;VAGINAL | Strength | 3.7%;2.86%;3.42% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;VAGINAL | Strength | 184MG;143.75MG;172.5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
